IP Library › Granted Patent US 12,257,207
Granted Patent B2
US 12,257,207 · App. 17/193,834 · Granted Mar 25, 2025

Medical pressure therapy device and components thereof

Inventors: Jonas Elderstiern (Oslo, NO); Hannes Ulvegard (Oslo, NO); Ronny Brakhya (Oslo, NO); Robert Axelsson (Oslo, NO); Juho Laasanen (Oslo, NO); Iacob Mathiesen (Oslo, NO); Arnar Kristjansson (Oslo, NO)
Assignee: OTIVIO AS
A61H9/0007A61G10/02A61H1/00A61H9/0078A61H9/0092A61H2201/0103A61H2201/0107A61H2201/0176A61H2201/0192A61H2201/1409A61H2201/164A61H2201/1642A61H2201/165A61H2201/169A61H2201/50A61H2201/5038A61H2201/5058A61H2201/5097A61H2205/106A61H2205/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,257,207
App. No.
17/193,834
Granted
Mar 25, 2025
Kind
B2
Abstract

A pressure therapy device includes a pressure chamber, an inflatable padding, a seal, and a positioning mechanism. The pressure chamber has an opening arranged for admitting the inflatable padding and a limb of a user. The inflatable padding is inflatable to enclose and fix the limb in position. The seal covers the opening, including the inflatable padding and the limb to seal the pressure chamber from ambient atmospheric pressure. A pump unit is provided to generate a non-atmospheric pressure within the pressure chamber and includes a first valve system and a piston with safety release features for preventing unsafe pressure levels.

Claims (38)

1. A pressure therapy device, comprising:

a pressure chamber having a first end and a second end, the first end comprising an upper edge defining an opening;

an inflatable padding positioned in the opening and extending from an interior region of the pressure chamber through the opening, a proximal portion of the inflatable padding projecting beyond the upper edge of the pressure chamber in a proximal direction; and

a seal secured to the first end of the pressure chamber and arranged to enclose the inflatable padding and the interior region of the pressure chamber from ambient pressure when sealing against a limb of a user;

wherein the inflatable padding is configured to be inflatable to narrow the opening and to separate the limb from contact with the pressure chamber;

wherein the inflatable padding defines a distal termination in the interior region of the pressure chamber and a proximal termination opposite the distal termination, a posterior portion of the distal termination of the inflatable padding defining a first plane and an anterior portion of the distal termination of the inflatable padding defining a second plane oblique to the first plane.

2. The pressure therapy device of claim 1 , wherein the inflatable padding includes at least two air chambers.

3. The pressure therapy device of claim 2 , wherein each of the at least two air chambers comprises a cylinder having a closed distal end and a closed proximal end.

4. The pressure therapy device of claim 1 , wherein the proximal portion of the inflatable padding projects beyond the upper edge of the pressure chamber in a proximal direction at a distance of 5 to 20 mm.

5. The pressure therapy device of claim 1 , wherein a length of the inflatable padding from the distal termination to the proximal termination varies along a circumference of the opening of the pressure chamber.

6. The pressure therapy device of claim 5 , wherein a posterior length of the inflatable padding from the distal termination to the proximal termination is greater than an anterior length of the inflatable padding from the distal termination to the proximal termination.

7. The pressure therapy device of claim 5 , wherein the length of the inflatable padding from the distal termination to the proximal termination continuously decreases from a posterior side of the inflatable padding to an anterior side of the inflatable padding.

8. The pressure therapy device of claim 1 , wherein the inflatable padding defines an interior volume sealed from the pressure chamber, such that a pressure within the interior volume may differ from a pressure within the interior volume of the pressure chamber.

9. The pressure therapy device of claim 1 , wherein the inflatable padding includes a valve in communication with ambient pressure.

10. The pressure therapy device of claim 1 , wherein the seal comprises a frustoconical cuff defining a distal end and a proximal end, the proximal end defining a center axis eccentric to a center axis of the distal end in a posterior direction.

11. The pressure therapy device of claim 10 , wherein the seal further comprises a protrusion extending from an exterior surface of the frustoconical cuff.

12. The pressure therapy device of claim 1 , comprising an elastic support in the interior region of the pressure chamber opposite the inflatable padding, the elastic support defining an arcuate shape.

13. The pressure therapy device of claim 12 , wherein the elastic support is hollow.

14. A method of using a pressure therapy device, the method comprising:

obtaining a pressure chamber having a first end and a second end, the first end comprising an upper edge defining an opening;

providing an inflatable padding in the opening of the pressure chamber, the inflatable padding positioned in the opening and extending from an interior region of the pressure chamber through the opening, a proximal portion of the inflatable padding projecting beyond the upper edge of the pressure chamber in a proximal direction;

inserting a limb into the pressure chamber through the inflatable padding and the opening of the pressure chamber;

providing a seal for sealing against the limb and enclosing the inflatable padding and the interior region of the pressure chamber from ambient pressure; and

generating a negative pressure in the pressure chamber;

wherein the inflatable padding prevents the limb from contacting the pressure chamber without sealing the interior region of the pressure chamber.

15. The method according to claim 14 , wherein the method further comprises:

releasing the negative pressure in the pressure chamber; and

generating an overpressure in the inflatable padding for massaging the limb.

16. The method according to claim 15 , wherein the inflatable padding defines an interior volume sealed from the pressure chamber, such that a pressure within the interior volume differs from a pressure within the interior of the pressure chamber during the generation of an overpressure in the inflatable padding.

17. The method according to claim 14 , wherein during use of the pressure therapy device the limb only contacts the inflatable padding and the seal of the pressure therapy device.

18. The method according to claim 17 , wherein the limb is suspended in the pressure chamber by the inflated inflatable padding.

19. The method according to claim 14 , wherein the method further comprises:

inflating the inflatable padding about the limb before or during the generation of the negative pressure in the pressure chamber;

wherein the inflated inflatable padding secures the limb in the opening of the pressure chamber relative to the pressure chamber.

20. The method according to claim 14 , wherein the method further comprises:

contacting an elastic support within the pressure chamber with the limb during insertion of the limb into the pressure chamber; and

inflating the inflatable padding about the limb before or during the generation of the negative pressure in the pressure chamber;

wherein the inflated inflatable padding and the elastic support secure a position of the limb in the opening of the pressure chamber relative to the pressure chamber.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2021
From: ELDERSTIERN, JONAS; ULVEGARD, HANNES; BRAKHYA, RONNY; AXELSSON, ROBERT; LAASANEN, JUHO; MATHIESEN, IACOB; KRISTJANSSON, ARNAR
To: OTIVIO AS
Reel/Frame 055512/0612 →
Continuity (5)
Continuation 16148556 · Oct 1, 2018
Continuation 16148538 · Oct 1, 2018
Continuation 16148566 · Oct 1, 2018
Provisional Application 62565534 · Sep 29, 2017
Related Publication 20210186797A1 · Jun 24, 2021
References Cited (165)
US 1071103A · Sims · 1913 [cited by applicant]
US 1110494A · Kellogg · 1914 [cited by applicant]
US 1399095A · Webb · 1921 [cited by applicant]
US 2113253A · Gray · 1938 [cited by applicant]
US 2168611A · Thompson · 1939 [cited by applicant]
US 2272481A · Rinkes et al. · 1942 [cited by applicant]
US 2626601A · Riley · 1953 [cited by applicant]
US 2684631A · Anthony et al. · 1954 [cited by applicant]
US 2702552A · Moodie · 1955 [cited by applicant]
US 2913293A · Dibley et al. · 1959 [cited by applicant]
US 3094983A · Macleod · 1963 [cited by applicant]
US 3217707A · Werding · 1965 [cited by applicant]
US 3286711A · Macleod · 1966 [cited by applicant]
US 3292613A · Macleod · 1966 [cited by applicant]
US 3391692A · Spielberg · 1968 [cited by applicant]
US 3403673A · Macleod · 1968 [cited by applicant]
US 3465748A · Kravchenko · 1969 [cited by applicant]
US 3565065A · Biggs, Jr. et al. · 1971 [cited by applicant]
US 3654919A · Birtwell · 1972 [cited by applicant]
US 3744491A · Fischer · 1973 [cited by applicant]
US 3757806A · Bhaskar et al. · 1973 [cited by applicant]
US 3859989A · Spielberg · 1975 [cited by examiner]
US 3878839A · Norton et al. · 1975 [cited by applicant]
US 3896794A · McGrath · 1975 [cited by applicant]
US 3977396A · Cartier · 1976 [cited by applicant]
US 4003371A · Fischer · 1977 [cited by examiner]
US 4054129A · Byars et al. · 1977 [cited by applicant]
US 4075935A · Panigati · 1978 [cited by applicant]
US 4149529A · Copeland et al. · 1979 [cited by applicant]
US 4186732A · Christoffel · 1980 [cited by applicant]
US 4269175A · Dillion · 1981 [cited by applicant]
US 4343302A · Dillon · 1982 [cited by applicant]
US 4376437A · Sundheim et al. · 1983 [cited by applicant]
US 4418690A · Mummert · 1983 [cited by applicant]
US 4421109A · Thornton · 1983 [cited by applicant]
US 4648392A · Cartier et al. · 1987 [cited by applicant]
US 4667672A · Romanowski · 1987 [cited by applicant]
US 4945901A · Burcke, Jr. · 1990 [cited by applicant]
US 4986260A · Iams et al. · 1991 [cited by applicant]
US 5000164A · Cooper · 1991 [cited by applicant]
US 5009251A · Pike et al. · 1991 [cited by applicant]
US 5029579A · Trammell · 1991 [cited by applicant]
US 5063910A · Cartier · 1991 [cited by applicant]
US 5074285A · Wright · 1991 [cited by applicant]
US 5192198A · Gebauer et al. · 1993 [cited by applicant]
US 5241958A · Noeldner · 1993 [cited by applicant]
US 5279283A · Dillon · 1994 [cited by applicant]
US 5297580A · Thurman · 1994 [cited by applicant]
US 5300103A · Stempel et al. · 1994 [cited by applicant]
US 5358467A · Milstein et al. · 1994 [cited by applicant]
US 5413599A · Imachi et al. · 1995 [cited by applicant]
US 5425742A · Joy · 1995 [cited by examiner]
US 5458562A · Cooper · 1995 [cited by applicant]
US 5507312A · Dillman · 1996 [cited by applicant]
US 5514079A · Dillon · 1996 [cited by applicant]
US 5669872A · Fox · 1997 [cited by examiner]
US 5683438A · Grahn · 1997 [cited by applicant]
US 5688225A · Walker · 1997 [cited by applicant]
US 5697920A · Gibbons · 1997 [cited by applicant]
US 5916183A · Reid · 1999 [cited by applicant]
US 6027464A · Dahlquist · 2000 [cited by applicant]
US 6129688A · Arkans · 2000 [cited by applicant]
US 6149674A · Borders · 2000 [cited by applicant]
US 6277052B1 · Howard · 2001 [cited by applicant]
US 6423017B2 · Brotz · 2002 [cited by applicant]
US 6565593B2 · Diana · 2003 [cited by applicant]
US 6656208B2 · Grahn et al. · 2003 [cited by applicant]
US 6974442B2 · Grahn et al. · 2005 [cited by applicant]
US 7160316B2 · Hamilton et al. · 2007 [cited by applicant]
US 7691084B2 · Knighton et al. · 2010 [cited by applicant]
US 7717869B2 · Eischen, Sr. · 2010 [cited by applicant]
US 7771402B2 · Marasco · 2010 [cited by applicant]
US 7833179B2 · Filtvedt et al. · 2010 [cited by applicant]
US 7833180B2 · Filtvedt et al. · 2010 [cited by applicant]
US 7896823B2 · Mangrum et al. · 2011 [cited by applicant]
US 7896825B2 · Atkinson et al. · 2011 [cited by applicant]
US 7947068B2 · Grahn et al. · 2011 [cited by applicant]
US 8021314B2 · Filtvedt et al. · 2011 [cited by applicant]
US 8100887B2 · Weston et al. · 2012 [cited by applicant]
US 8182521B2 · Kane et al. · 2012 [cited by applicant]
US 8226586B2 · Cazzini et al. · 2012 [cited by applicant]
US 8287474B1 · Koenig et al. · 2012 [cited by applicant]
US 8361001B2 · Filtvedt et al. · 2013 [cited by applicant]
US 8460355B2 · Cazzini et al. · 2013 [cited by applicant]
US 8603150B2 · Kane et al. · 2013 [cited by applicant]
US 8657796B2 · Marasco · 2014 [cited by applicant]
US 8657864B2 · Rein et al. · 2014 [cited by applicant]
US 8663198B2 · Buan et al. · 2014 [cited by applicant]
US 8728016B2 · Reeves et al. · 2014 [cited by applicant]
US 8784346B2 · Barak et al. · 2014 [cited by applicant]
US 8821422B2 · Filtvedt et al. · 2014 [cited by applicant]
US 10420699B2 · Loori et al. · 2019 [cited by applicant]
US 20020007836A1 · Weyergans · 2002 [cited by applicant]
US 20030097163A1 · Kane et al. · 2003 [cited by applicant]
US 20030125649A1 · McIntosh et al. · 2003 [cited by applicant]
US 20030144690A1 · Zheng et al. · 2003 [cited by applicant]
US 20040010212A1 · Kuiper · 2004 [cited by examiner]
US 20040030411A1 · Caspers · 2004 [cited by applicant]
US 20040154666A1 · Gessat et al. · 2004 [cited by applicant]
US 20040210176A1 · Diana · 2004 [cited by applicant]
US 20050027218A1 · Filtvedt et al. · 2005 [cited by applicant]
US 20050137446A1 · Rastegar et al. · 2005 [cited by applicant]
US 20050261615A1 · Weston · 2005 [cited by applicant]
US 20080015640A1 · Kaiser · 2008 [cited by applicant]
US 20080097252A1 · Babaev · 2008 [cited by applicant]
US 20080261615A1 · Kalhan · 2008 [cited by applicant]
US 20090048649A1 · Peret et al. · 2009 [cited by applicant]
US 20090107461A1 · Ulrey et al. · 2009 [cited by applicant]
US 20090143719A1 · Loori et al. · 2009 [cited by applicant]
US 20090177184A1 · Christensen et al. · 2009 [cited by applicant]
US 20090270910A1 · Hargens et al. · 2009 [cited by applicant]
US 20090312675A1 · Sampson et al. · 2009 [cited by applicant]
US 20100152633A1 · Rein et al. · 2010 [cited by applicant]
US 20110000484A1 · Melsheimer · 2011 [cited by applicant]
US 20110130712A1 · Topaz · 2011 [cited by applicant]
US 20110197554A1 · Ruetenik · 2011 [cited by applicant]
US 20110288458A1 · Jones et al. · 2011 [cited by applicant]
US 20110295168A1 · Mangrum et al. · 2011 [cited by applicant]
US 20120238924A1 · Avni · 2012 [cited by applicant]
US 20140128781A1 · Rein et al. · 2014 [cited by applicant]
US 20140276254A1 · Varga et al. · 2014 [cited by applicant]
US 20140276288A1 · Randolph et al. · 2014 [cited by applicant]
US 20150065931A1 · Alnabulsi et al. · 2015 [cited by applicant]
US 20150297909A1 · Peashock · 2015 [cited by applicant]
US 20160262971A1 · Doron et al. · 2016 [cited by applicant]
US 20170050020A1 · Yang · 2017 [cited by applicant]
CN 301338691S · 2010 [cited by applicant]
CN 205903203U · 2017 [cited by applicant]
EM 0026509370001 · 2015 [cited by applicant]
EM 0026509370002 · 2015 [cited by applicant]
EM 0026509370003 · 2015 [cited by applicant]
EM 0026509370004 · 2015 [cited by applicant]
EM 0026509370005 · 2015 [cited by applicant]
EP 1884226A1 · 2008 [cited by applicant]
EP 1929980A1 · 2008 [cited by applicant]
EP 1736132B1 · 2011 [cited by applicant]
FR 1562252A · 1969 [cited by applicant]
JP H10192354A · 1998 [cited by applicant]
JP 2005288068A · 2005 [cited by applicant]
JP 1267330S · 2006 [cited by applicant]
WO 9840039A1 · 1998 [cited by applicant]
WO 0180790A1 · 2001 [cited by applicant]
WO 03045289A1 · 2003 [cited by applicant]
WO 2004058131A2 · 2004 [cited by applicant]
Indian Office Action from Corresponding Indian Application No. 202017016268, Apr. 13, 2022. [cited by applicant]
Office Action from corresponding Japanese Application No. 2020-539151, May 24, 2022. [cited by applicant]
Allen et al., “Intermittent Pressure and Suction in the Treatment of Chronic Occlusive Arterial Disease,” The Journal of the American Medical Association, vol. 105, No. 25, Dec. 21, 1935, pp. 2029-2034. [cited by applicant]
De Takats, “Obliterative Vascular Disease: Preliminary Report on Treatment by Alternating Negative and Positive Pressure,” Journal of the American Medical Association, vol. 103, No. 25, Dec. 22, 1934, pp. 1920-1924. [cited by applicant]
Herrmann et al., “The Conservative Treatment of Arteriosclerotic Peripheral Vascular Diseases: Passive Vascular Exercises (Pavaex Therapy), ” Annals of Surgery, vol. 100, No. 4, Oct. 1934, pp. 750-760. [cited by applicant]
Herrmann et al., “Passive Vascular Exercises: Treatment of Peripheral Obliterative Arterial Diseases by Rhythmic Alternation of Environmental Pressure,” Archives of Surgery, vol. 29, No. 5, Nov. 1934, pp. 697-704. [cited by applicant]
Landis et al., “The Effects of Alternate Suction and Pressure on Blood Flow to the Lower Extremities,” The Journal of Clinical Investigation, vol. 12, No. 5, Sep. 1933, pp. 925-961. [cited by applicant]
Landis et al., “Treatment of Peripheral Vascular Disease by Means of Suction and Pressure,” Annals of Internal Medicine, vol. 9, No. 3, Sep. 1, 1935, pp. 264-273. [cited by applicant]
Meyer et al., “Bier's Hyperemic Treatment,” California State Journal of Medicine, vol. 8, No. 4, Apr. 1910, pp. 142-143. [cited by applicant]
Reid, “Diagnosis and Treatment of Peripheral Vascular Diseases,” The American Journal of Surgery, vol. 24, No. 1, Apr. 1934, pp. 11-35. [cited by applicant]
Theis et al., “Peripheral Circulatory Diseases Effect of Alternating Positive and Negative Pressure Treatments on Venous Blood and the Skin Temperatures: Preliminary Report,” The Journal of the American Medical Associat… [cited by applicant]
Goodney et al., “National Trends in Lower Extremity Bypass Surgery, Endovascular Interventions, and Major Amputations”, Journal of Vascular Surgery vol. 50 No. 1, Jul. 2009, pp. 54-60. [cited by applicant]
Hiramori et al., “Impact of Runoff Grade After Endovascular Therapy For Femoropopliteal Lesions”, Journal of Vascular Surgery, vol. 59, No. 3, Mar. 2014, pp. 720-727. [cited by applicant]
Norgren et al., “Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)”, Journal of Vascular Surgery, vol. 45, No. 1, Supplement S, Jan. 2007, p. S5A-S67A. [cited by applicant]
Rowe et al., “Patterns of Treatment for Peripheral Arterial Disease in the United States: 1996-2005”, Journal of Vascular Surgery vol. 49, No. 4, Apr. 2009, pp. 910-917. [cited by applicant]
Siracuse et al., “Results for Primary Bypass Versus Primary Angioplasty/Stent for Intermittent Claudication Due to Superficial Femoral Artery Occlusive Disease”, Journal of Vascular Surgery, vol. 55, No. 4, Apr. 2012, p… [cited by applicant]
“NANOVA Therapy System,” Acelity, retrieved from https://www.acelity.com/products/nanova-therapy-system-uk on Aug. 27, 2018, 11 Pages. [cited by applicant]
International Search Report from PCT Application No. PCT/IB2018/057616, Jan. 16, 2019. [cited by applicant]
Japanese Office Action from JP Application No. 2018-008307, Jan. 8, 2019. [cited by applicant]
Online Mail Order Catalog, Felissimo, Jan. 3, 2016, 6 Pages, https://www.felissimo.co.jp. [cited by applicant]
Japanese Office Action from corresponding Japanese Patent Application No. JP 2020-539151, Aug. 30, 2020. [cited by applicant]